Resumen
Ultrafiltration provides a generic method to discover ligands for protein drug targets with millimolar to micromolar K d, the typical range of fragment-based drug discovery. This method was tailored to a 96-well format, and cocktails of fragment-sized molecules, with molecular masses between 150 and 300 Da, were screened against medical structural genomics target proteins. The validity of the method was confirmed through competitive binding assays in the presence of ligands known to bind the target proteins.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 1589-1595 |
| Número de páginas | 7 |
| Publicación | Analytical and Bioanalytical Chemistry |
| Volumen | 401 |
| N.º | 5 |
| DOI | |
| Estado | Published - sept 2011 |
Nota bibliográfica
Funding Information:We thank Eric T. Larson for his critical review of the manuscript. This work was supported by National Institutes of Health grants P50GM64655 (SGPP), P01AI067921 (MSGPP), and AI34501.
Financiación
We thank Eric T. Larson for his critical review of the manuscript. This work was supported by National Institutes of Health grants P50GM64655 (SGPP), P01AI067921 (MSGPP), and AI34501.
| Financiadores | Número del financiador |
|---|---|
| MSGPP | |
| National Institutes of Health (NIH) | P50GM64655, P01AI067921 |
| National Institute of Allergy and Infectious Diseases | R56AI034501 |
ASJC Scopus subject areas
- Analytical Chemistry
- Biochemistry
Huella
Profundice en los temas de investigación de 'Screening a fragment cocktail library using ultrafiltration'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver